Prognostic factors of secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer
Open Access
- 1 January 2009
- journal article
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 20 (2), 101-106
- https://doi.org/10.3802/jgo.2009.20.2.101
Abstract
Bae J, et al. J Gynecol Oncol. 2009 Jun;20(2):101-106. https://doi.org/10.3802/jgo.2009.20.2.101Keywords
This publication has 24 references indexed in Scilit:
- Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum‐sensitive epithelial ovarian carcinomaCancer, 2006
- The role of secondary cytoreduction in the treatment of ovarian cancer: Hacettepe University experienceAmerican Journal of Obstetrics and Gynecology, 2006
- The role of secondary cytoreductive surgery for recurrent ovarian cancerGynecologic Oncology, 2005
- Surgical cytoreduction in recurrent ovarian carcinoma in patients with complete response to paclitaxel–platinumEuropean Journal of Surgical Oncology, 2005
- Critical evaluation of secondary cytoreduction in recurrent ovarian cancerGynecologic Oncology, 2004
- Secondary cytoreductive surgery for patients with relapsed epithelial ovarian carcinoma: Who benefits?Cancer, 2004
- Secondary cytoreductive surgery for recurrent epithelial ovarian cancerPublished by Wolters Kluwer Health ,2002
- Secondary Cytoreductive Surgery for Patients with Recurrent Epithelial Ovarian CarcinomaGynecologic Oncology, 2001
- Secondary Cytoreductive Surgery for Localized Intra-abdominal Recurrences in Epithelial Ovarian CancerGynecologic Oncology, 2001
- Recurrent ovarian carcinoma: Is there a place for surgery?Seminars in Surgical Oncology, 2000